Skip to main content
. 2020 Oct 19;16(10):e1008319. doi: 10.1371/journal.pcbi.1008319

Table 2. Counts of susceptible and resistant genomes used in this study, data are displayed as (Susceptible|Resistant).

Antibiotic Abv. K. pneumoniae M. tuberculosis S. enterica S. aureus
Amikacin AMK 1320|103 868|230
Amoxicillin/Clavulanate AMC 1489|400
Ampicillin AMP 1291|706
Ampicillin/Sulbactam SAM 90|1455
Aztreonam ATM 216|1407
Capreomycin CAP 846|214
Cefazolin CFZ 97|1570
Cefepime FEP 418|963
Cefoxitin FOX 667|828 1599|348
Ceftazidime CAZ 136|1488
Ceftiofur TIO 1602|393
Ceftriaxone CRO 80|1528 1601|397
Cefuroxime sodium CXM 91|1469
Chloramphenicol CHL 1864|88
Ciprofloxacin CIP 201|1424 752|243
Clindamycin CLI 444|144
Erythromycin ERY 1016|257
Ethambutol EMB 3889|484
Ethionamide ETO 167|123
Fusidic acid FA 1156|83
Gentamicin GEN 926|683 1639|329
Imipenem IPM 1160|478
Isoniazid INH 4098|1204
Kanamycin KAN 614|167
Levofloxacin LVX 349|1287
Meropenem MEM 1134|481
Methicillin MET 771|215
Moxifloxacin MXF 593|85
Ofloxacin OFX 182|176
Penicillin PEN 175|1063
Piperacillin/Tazobactam TZP 432|1048
Pyrazinamide PZA 3605|428
Rifampin RIF 4438|828
Streptomycin STR 2140|684 381|772
Sulfisoxazole FIS 1108|772
Tetracycline TET 739|778 867|1124
Tobramycin TOB 589|723
Trimethoprim/Sulfamethoxazole SXT 416|1251